The authors conducted a systematic review of published data on the association between diabetes mellitus and fracture. The authors searched MEDLINE through June 2006 and examined the reference lists of pertinent articles (limited to studies in humans). Summary relative risks and 95% confidence intervals were calculated with a random-effects model. The 16 eligible studies (two case-control studies and 14 cohort studies) included 836,941 participants and 139,531 incident cases of fracture. Type 2 diabetes was associated with an increased risk of hip fracture in both men (summary relative risk (RR) ¼ 2.8, 95% confidence interval (CI): 1.2, 6.6) and women (summary RR ¼ 2.1, 95% CI: 1.6, 2.7). Results were consistent between studies of men and women and between studies conducted in the United States and Europe. The association between type of diabetes and hip fracture incidence was stronger for type 1 diabetes (summary RR ¼ 6.3, 95% CI: 2.6, 15.1) than for type 2 diabetes (summary RR ¼ 1.7, 95% CI: 1.3, 2.2). Type 2 diabetes was weakly associated with fractures at other sites, and most effect estimates were not statistically significant. These findings strongly support an association between both type 1 and type 2 diabetes and increased risk of hip fracture in men and women.
Diabetes mellitus and low-trauma fracture are major causes of morbidity and premature mortality worldwide. Although several observational studies have investigated the association between diabetes and risk of fracture, the role of diabetes as a risk factor for osteoporosis and lowtrauma fracture remains unsettled.
Bone mineral density appears to be reduced in patients with type 1 diabetes in most (1-4) but not all (5, 6) studies. There have been conflicting reports about bone mineral density among patients with type 2 diabetes (3, 4, (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) ; in some studies, bone mineral density was reduced (7, 9) , and in others it was increased (8, (10) (11) (12) or unchanged (13) (14) (15) (16) (17) (18) .
In addition, uncertainty exists about the relation between diabetes and fracture incidence. Several studies have examined the risk of fracture in persons with type 1 diabetes (9, (14) (15) (16) (19) (20) (21) ; the risk of hip fracture appeared to be increased in some (9, 14, (19) (20) (21) , but not all (15, 16) . Studies of the association between type 2 diabetes and fracture risk have demonstrated inconsistent conclusions (4, 8, 9, 11, 12, 15, (21) (22) (23) (24) (25) (26) (27) : Reported associations have been positive (12, (21) (22) (23) (24) (25) (26) (27) , null (4, 8, 9) , or even inverse (11, 15) , and in some studies an association was observed only in women (12, 14, 21, 22, 28) . Type 2 diabetes is strongly associated with high bone mineral density and obesity, factors that provide protection from most fractures (11, 12, 29) . Interpretation of these findings, however, has been hampered by the low frequency of occurrence of both conditions in the same person, which results in a lack of statistical power to adequately analyze this association in many studies.
We conducted a systematic review of case-control and cohort studies to summarize the epidemiologic evidence on the association between diabetes and fracture risk and to identify possible sources of heterogeneity between studies. We also evaluated whether the association varied by sex, type of diabetes, or fracture site.
MATERIALS AND METHODS

Search strategy
We searched MEDLINE through June 2006 using the keyword ''fracture'' combined with ''diabetes mellitus,'' ''diabetes,'' ''glucose,'' or ''insulin.'' We limited the search to studies carried out in humans. We also reviewed the reference lists of the identified publications for additional pertinent studies. No language restrictions were imposed.
Eligibility criteria
The 20 epidemiologic studies considered for inclusion in this meta-analysis were six case-control studies and 14 cohort studies on the association between diabetes and the incidence of low-trauma hip, distal forearm, proximal humerus, ankle, foot, nonvertebral, or vertebral fracture (8, 9, 12, 14-16, 19-21, 23-26, 28-34) . The fractures were confirmed through review of radiologic reports, radiographs, or medical records. Studies were excluded if they did not provide data that allowed calculation of standard errors for effect estimates and if the estimates had not been adjusted for age. When there were multiple publications from the same population or cohort, only data from the most recent report were included. We excluded two studies (24, 27) because of overlapping publication and two studies (16, 32) that reported only crude data that were not adjusted for age.
Data extraction
For each publication included, we extracted data on first author's surname, year of publication, country, study design, numbers of exposed and unexposed subjects, source of controls (for case-control studies), follow-up period (for cohort studies), age, sex, type of diabetes (type 1, type 2, or both), risk estimates and corresponding confidence intervals, and factors controlled for by matching or multivariable analysis. From each study, we extracted the risk estimates that reflected the greatest degree of control for potential confounding. Information on study design, participant characteristics, measurement of fractures, adjustment for potential confounders, and estimates of association was extracted independently by two reviewers (M. J. and R. M. V.). Discrepancies were resolved through discussion.
Statistical analysis
Three measures of association were reported: odds ratios (case-control studies), incidence rate ratios (cohort studies), and standardized incidence ratios (cohort studies with an external comparison group). For simplicity, we will refer to all three types of measures as relative risks. Because the frequency at which low-trauma fractures occur is relatively low, odds ratios in case-control studies and rate ratios in cohort studies yield similar estimates of relative risk (35) .
We used the logarithm of the relative risk with its standard error for the meta-analysis. Summary relative risk estimates and corresponding 95 percent confidence intervals were derived by the method of DerSimonian and Laird (36) using a random-effects model, which incorporates betweenstudy variability. Statistical heterogeneity between studies was evaluated with Cochran's Q test (37) . To assess sources of heterogeneity, we conducted a meta-regression analysis with region (United States/Europe), sex (men/women and both sexes combined), fracture site, study design, duration of follow-up (in cohort studies), and type of diabetes as independent variables and log relative risk as the dependent variable. Publication bias was assessed through visual inspection of funnel plots (38) . In these funnel plots, the relative risks were displayed against the inverse of the square of the standard error (a measure of the precision of the studies). Formal statistical assessment of funnel plot asymmetry was done with Egger's regression asymmetry test (39) . We also used Begg's adjusted rank correlation test (39) . Statistical analyses were carried out with Stata, version 9.0 (Stata Corporation, College Station, Texas). P values less than 0.05 were considered statistically significant. All statistical tests were two-sided.
RESULTS
Study characteristics
Sixteen independent studies met the predefined inclusion criteria. Of these 16 studies, two were case-control studies (20, 34) (table 1) , 13 were cohort studies that used incidence rate ratios as the measure of relative risk (8, 9, 12, 14, 15, 21, 23, 25, (28) (29) (30) (31) 33) (table 2) , and one was a cohort study that used standardized hospitalization ratio as the measure of relative risk (19) . Seven studies were conducted in the United States (9, 12, 15, 21, 23, 33, 34) , eight in Europe (14, 19, 20, 25, (28) (29) (30) (31) , and one in Australia (8) . Six studies included cases of type 1 diabetes, 12 studies included cases of type 2 diabetes, and three studies included both types of diabetes. The outcomes evaluated included incident hip fracture in 13 studies (8, 9, 12, 14, 15, 19-21, 23, 25, 28, 29, 34) , all nonvertebral fractures combined in eight studies (8, 12, 20, (28) (29) (30) (31) 33) , distal forearm fracture in seven studies (8, 12, 15, 20, 29, 30, 34) , proximal humerus fracture in five studies (8, 12, 15, 30, 34) , foot fracture in two studies (12, 34) , vertebral fracture (based on spine radiographs) in four studies (12, 15, 20, 30) , and ankle fracture in three studies (8, 12, 30) . In the primary meta-analysis of diabetes and fracture incidence, we included both the two case-control studies (20, 34) and the 14 cohort studies (8, 9, 12, 14, 15, 19, 21, 23, 25, (28) (29) (30) (31) 33) . These sixteen studies comprised 836,941 participants and 139,531 incident cases of fracture.
Hip fracture incidence and type 1 and type 2 diabetes Figure 1 shows individual study results and the overall summary results for the one case-control and 11 cohort studies of type 2 diabetes and hip fracture incidence. Eight of these 12 studies found a statistically significant positive association between type 2 diabetes and hip fracture incidence. In one of the cohort studies (15), a significant inverse association between type 2 diabetes and hip fracture (relative risk (RR) ¼ 0.8, 95 percent confidence interval (CI): 0.5, 0.9) was reported, but when we recalculated the 95 percent confidence interval based on the derived standard error, the upper limit crossed 1 (RR ¼ 0.8, 95 percent CI: 0.6, 1.02). The range of individual relative risks was 0.6-9.2, and the summary relative risk for all 12 studies was 1.7 (95 percent CI: 1.3, 2.2). Heterogeneity among studies was found (Q ¼ 58.1; p for heterogeneity (p het ) < 0.001). In a sensitivity analysis in which one study at a time was excluded and all other studies were included, we consistently found a statistically significant positive association between type 2 diabetes and hip fracture incidence (range of summary RRs, 1.6-1. In an analysis excluding these studies, the association between type 2 diabetes and hip fracture was somewhat stronger (summary RR ¼ 1.8, 95 percent CI: 1.5, 2.2), and the test for heterogeneity was not statistically significant (Q ¼ 12.2; p het ¼ 0.14). Figure 2 shows individual study results and the overall summary results for the one case-control and five cohort studies of type 1 diabetes and hip fracture incidence. All six of these studies found a statistically significant positive association between type 1 diabetes and hip fracture incidence (range of individual RRs, 1.7-12.3); the summary relative risk for all six studies combined was 6.3 (95 percent CI: 2.6, 15.1). Heterogeneity among studies was significant (Q ¼ 89.2; p het < 0.001). In a sensitivity analysis excluding one study at a time, we consistently found a statistically significant positive association between type 1 diabetes and hip fracture incidence (range of summary RRs, 5.5-8.9). The case-control study by Vestergaard et al. (20) contributed most to heterogeneity. In an analysis excluding this study, the association between type 1 diabetes and hip fracture became stronger (summary RR ¼ 8.9, 95 percent CI: 7.1, 11.2), and the test for heterogeneity was not statistically significant (Q ¼ 2.9; p het ¼ 0.57).
We also conducted subgroup meta-analyses by study design, geographic area, sex, type of diabetes, and duration of follow-up (table 3) . The association between type 2 diabetes and hip fracture incidence was somewhat stronger in cohort studies than in one case-control study and stronger in men than in women, although differences were not statistically significant. Results were consistent for studies conducted in Europe and in the United States. For type of diabetes, the summary estimate was stronger for type 1 diabetes than for type 2 diabetes; there was heterogeneity by type of diabetes (p het < 0.001). Finally, the summary estimate was stronger for the four cohorts with 10 or more years of follow-up (summary RR ¼ 2.7, 95 percent CI: 1.7, 4.4) than for the six cohorts with follow-up durations of less than 10 years (RR ¼ 1.6, 95 percent CI: 1.3, 2.0); there was heterogeneity among studies by duration of follow-up (<10 years vs. 10 years) (p het ¼ 0.02). Age, physical activity, and body mass index are potentially the most important known confounders for the positive association between type 2 diabetes and hip fracture risk. When we restricted the meta-analysis to studies that controlled for these variables (12, 21, 25) , the association between type 2 diabetes and hip fracture remained (summary RR ¼ 2.6, 95 percent CI: 1.5, 4.5).
Other fracture sites
Of one case-control and seven cohort studies of type 2 diabetes and all nonvertebral fractures (8, 12, 20, (28) (29) (30) (31) 33) , four (12, 20, 28, 33) found a statistically significant positive association and four (8, (29) (30) (31) found no association (tables 1 and 2) . When all eight studies were analyzed, a statistically significant association between type 2 diabetes and risk of any fracture was found (summary RR ¼ 1.2, 95 percent CI: 1.01, 1.5). However, there was statistically significant heterogeneity among studies (Q ¼ 14.9; p het ¼ 0.02). A sensitivity analysis identified the study by Ivers et al. (8) as contributing most to heterogeneity. In an analysis excluding this study, the association between type 2 diabetes and any fracture was somewhat stronger (summary RR ¼ 1.3, 95 percent CI: 1.1, 1.5), and the test for heterogeneity was no longer statistically significant (Q ¼ 10.5; p het ¼ 0.11). There was no significant association between type 2 diabetes and fracture of the distal forearm (summary RR ¼ 0.98, 95 percent CI: 0.8, 1.2), ankle (RR ¼ 1.3, 95 percent CI: 0.9, 2.0), proximal humerus (RR ¼ 1.3, 95 percent CI: 0.8, 2.2), or vertebra (RR ¼ 1.2, 95 percent CI: 0.7, 1.2). The association between type 2 diabetes and foot fracture (RR ¼ 1.3, 95 percent CI: 1.1, 1.7) was statistically significant but was based on only two studies (12, 34).
Publication bias
There was no funnel plot asymmetry for the association between either type of diabetes and hip fracture risk (data not shown). P values for Begg's adjusted rank correlation test and Egger's regression asymmetry test were 0.41 and 0.42, respectively, indicating a low probability of publication bias.
DISCUSSION
Findings from this meta-analysis indicate that both type 1 and type 2 diabetes were associated with significantly increased risk of hip fracture; the association with type 1 diabetes was stronger than that with type 2 diabetes. The results were consistent for studies carried out in the United States and in Europe. The association was observed in both women and men.
Our analysis must be interpreted in the context of the limitations of the available data. Four of the studies (25 percent) did not distinguish between type 1 and type 2 diabetes (15, 23, 25, 34) . Because type 1 diabetes (which accounts for 5-10 percent of all diagnosed cases of diabetes (40)) may be more strongly related to hip fracture (9, 14, 19, FIGURE 2. Association between type 1 diabetes mellitus and risk of hip fracture in case-control and cohort studies. Each square shows the studyspecific relative risk (RR) estimate (the size of the square reflects the study-specific statistical weight, that is, the inverse of the variance), and the horizontal line shows the related 95 confidence interval (CI). The diamond shows the summary RR estimate, and its width represents the corresponding 95% CI. All statistical tests were two-sided. Statistical heterogeneity between studies was assessed with Cochran's Q test.
than Whites (41) . In this meta-analysis, we were unable to conduct separate analyses by ethnicity. In addition, only two of 16 studies included in the meta-analysis measured and controlled for bone mineral density (29, 31) . Thus, it was not possible for us to evaluate the impact of controlling for bone mineral density on the relation between diabetes and fracture risk. Type 2 diabetes and hip fracture share similar risk factors, including age and physical inactivity, and opposing risk factors, including obesity. Thus, the observed increased risk of hip fracture associated with a history of type 2 diabetes may reflect confounding by these risk factors. However, a positive association between diabetes and hip fracture risk remained when we limited the meta-analysis to studies that controlled for age, physical activity, and body mass index.
Discrepancies among studies investigating the relation of diabetes with hip fracture risk according to sex may be attributable to small samples that produced insufficient statistical power to detect some relations in the individual studies. Because this meta-analysis included a large number of studies, we could assess the association according to sex with high precision. The association between type 2 diabetes and hip fracture was slightly stronger in men than in women, but this difference could have easily been due to chance, because the number of cases in men was relatively small.
The mechanisms whereby diabetes increases fracture risk are not entirely clear. The putative mechanisms include impaired bone quality due to the lower bone mineral density (1, 4) and long-term bone loss (42) observed among patients with type 1 diabetes. Another possible cause of the increased risk of low-trauma fracture in both type 1 and type 2 diabetes is diabetes-related comorbidity (6, 8, 43, 44) , such as diabetic retinopathy, peripheral neuropathy, and cerebral stroke or hypoglycemia, which may increase risk of falling. The combination of poor bone quality and frequent falls would be expected to increase the risk of fracture independently of bone mineral density. Evidence regarding a direct relation of better glycemic control with reduced risk of fracture is very weak (8) .
Our results have important clinical and public health implications. Osteoporotic fractures and diabetes mellitus continue to be important medical, social, and economic concerns to society. In the United States, approximately 8 percent of adults have diabetes (45) , and it has been predicted that the number of Americans with diagnosed diabetes will increase by 165 percent in the coming half century, from 11 million in 2000 to 29 million in 2050 (46) . The prevalence of diabetes has also increased rapidly in other developed countries and in many developing countries. Diabetes prevalence will continue to escalate worldwide as a result of the aging of the population and the growing obesity epidemic; thus, it will further contribute to the public health burden of low-trauma fractures.
In conclusion, the results of this meta-analysis strongly support an association between type 1 and type 2 diabetes and increased risk of hip fracture in both women and men. With a worldwide increasing prevalence of diabetes, the contribution of diabetes to the incidence of low-trauma fracture may increase. These findings emphasize the need for fracture prevention strategies in patients with diabetes.
